nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Anti-cytokine therapies for psoriasis
|
Nograles, Kristine E. |
|
2011 |
317 |
9 |
p. 1293-1300 8 p. |
artikel |
2 |
BAFF inhibition: A new class of drugs for the treatment of autoimmunity
|
Liu, Zheng |
|
2011 |
317 |
9 |
p. 1270-1277 8 p. |
artikel |
3 |
Beta-interferon for multiple sclerosis
|
Rudick, Richard A. |
|
2011 |
317 |
9 |
p. 1301-1311 11 p. |
artikel |
4 |
Development of anti-CD20 therapy for multiple sclerosis
|
Bartok, Beatrix |
|
2011 |
317 |
9 |
p. 1312-1318 7 p. |
artikel |
5 |
Editorial Board
|
|
|
2011 |
317 |
9 |
p. IFC- 1 p. |
artikel |
6 |
Erythropoietin for oncology supportive care
|
McKinney, Matthew |
|
2011 |
317 |
9 |
p. 1246-1254 9 p. |
artikel |
7 |
GLP-1 for type 2 diabetes
|
Ahrén, Bo |
|
2011 |
317 |
9 |
p. 1239-1245 7 p. |
artikel |
8 |
Immunomodulatory therapy of cancer with T cell-engaging BiTE antibody blinatumomab
|
Nagorsen, Dirk |
|
2011 |
317 |
9 |
p. 1255-1260 6 p. |
artikel |
9 |
Inhibition of IL6 in rheumatoid arthritis and juvenile idiopathic arthritis
|
Mircic, Maja |
|
2011 |
317 |
9 |
p. 1286-1292 7 p. |
artikel |
10 |
Introduction to current and future protein therapeutics: A protein engineering perspective
|
Carter, Paul J. |
|
2011 |
317 |
9 |
p. 1261-1269 9 p. |
artikel |
11 |
Modulation of antibody effector function
|
Desjarlais, John R. |
|
2011 |
317 |
9 |
p. 1278-1285 8 p. |
artikel |